Oudshoorn M - Search Results

1

A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies.

Bouma GJ, Schanz U, Oudshoorn M, van der Meer-Prins PM, Roelen DL, van Rood JJ, Claas FH. Bouma GJ, et al. Among authors: oudshoorn m. Bone Marrow Transplant. 1996 Jan;17(1):19-23. Bone Marrow Transplant. 1996. PMID: 8673049

2

HLAMatchmaker algorithm is not a suitable tool to predict the alloreactive cytotoxic T-lymphocyte response in vitro.

Dankers MK, Heemskerk MB, Duquesnoy RJ, Doxiadis II, Oudshoorn M, Roelen DL, Claas FH. Dankers MK, et al. Among authors: oudshoorn m. Transplantation. 2004 Jul 15;78(1):165-7. doi: 10.1097/01.tp.0000133511.94487.d3. Transplantation. 2004. PMID: 15257058

3

Laboratory procedures used to select an unrelated HLA matched bone marrow donor.

van Leeuwen A, Oudshoorn M, Schreuder IM, Giphart MJ, Claas FH, van Rood JJ. van Leeuwen A, et al. Among authors: oudshoorn m. Bone Marrow Transplant. 1993;11 Suppl 1:13-6. Bone Marrow Transplant. 1993. PMID: 8448537

4

Bone Marrow Donors Worldwide and cord blood stem cell transplantation.

van Rood JJ, Schipper RF, Bakker JN, van der Zanden HG, Oudshoorn M. van Rood JJ, et al. Among authors: oudshoorn m. Bone Marrow Transplant. 1998 Jul;22 Suppl 1:S19-21. Bone Marrow Transplant. 1998. PMID: 9715877

5

An HLA matched donor! An HLA matched donor? What do you mean by: HLA matched donor?

van Rood JJ, Oudshoorn M. van Rood JJ, et al. Among authors: oudshoorn m. Bone Marrow Transplant. 1998 Jul;22 Suppl 1:S83. Bone Marrow Transplant. 1998. PMID: 9715900

6

Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data.

Roelen DL, Stobbe I, Young NT, van Bree SP, Doxiadis II, Oudshoorn M, Morris PJ, Wood KJ, Claas FH. Roelen DL, et al. Among authors: oudshoorn m. Hum Immunol. 2001 Jul;62(7):661-7. doi: 10.1016/s0198-8859(01)00263-4. Hum Immunol. 2001. PMID: 11423171

7

Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation.

Heemskerk MB, Cornelissen JJ, Roelen DL, van Rood JJ, Claas FH, Doxiadis II, Oudshoorn M. Heemskerk MB, et al. Among authors: oudshoorn m. Bone Marrow Transplant. 2007 Aug;40(3):193-200. doi: 10.1038/sj.bmt.1705721. Epub 2007 May 28. Bone Marrow Transplant. 2007. PMID: 17529995

8

Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?

van Rood JJ, Oudshoorn M. van Rood JJ, et al. Among authors: oudshoorn m. Bone Marrow Transplant. 2008 Jan;41(1):1-9. doi: 10.1038/sj.bmt.1705866. Epub 2007 Nov 5. Bone Marrow Transplant. 2008. PMID: 17982505

9

Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response.

Heemskerk MB, Roelen DL, Dankers MK, van Rood JJ, Claas FH, Doxiadis II, Oudshoorn M. Heemskerk MB, et al. Among authors: oudshoorn m. Hum Immunol. 2005 Sep;66(9):969-76. doi: 10.1016/j.humimm.2005.06.007. Epub 2005 Oct 10. Hum Immunol. 2005. PMID: 16360836

10

When selecting an HLA mismatched stem cell donor consider donor immune status.

van Rood JJ, Oudshoorn M. van Rood JJ, et al. Among authors: oudshoorn m. Curr Opin Immunol. 2009 Oct;21(5):538-43. doi: 10.1016/j.coi.2009.07.016. Epub 2009 Sep 6. Curr Opin Immunol. 2009. PMID: 19735996 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters